Antifungal treatment in patients with cancer

Journal of Internal Medicine, Supplement

Volumn 242, Issue 740, 1997, Pages 89-94

  Viscoli, C ^a  

^a NONE

Author keywords

Cancer; Infections; Therapy

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; AMPHOTERICIN B;

ANTIBIOTIC RESISTANCE; ASPERGILLOSIS; CANDIDA ALBICANS; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HOSPITAL INFECTION; HUMAN; INFECTION; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; INTRAVESICAL DRUG ADMINISTRATION; KIDNEY FAILURE; MYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; DRUG COMBINATION; NEOPLASM; REVIEW;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; DRUG THERAPY, COMBINATION; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MYCOSES; NEOPLASMS;

EID: 0030883470     PISSN: 09557873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Donnelly JP. Chemoprophylaxis for the prevention of bacterial and fungal infections. In: Klastersky J. ed. Infectious Complications of Cancer. Kluwer Academic Publishers: Boston 1995: 45-82.
2. Klastersky J. Empiric therapy for bacterial infections in neutropenic patients. In: Klastersky J, ed. Infectious Complications of Cancer. Kluwer Academic Publishers: Boston 1995; 101-12.